Analyst Insights to Review Jan. 30th: HAIN, GTXI, TIN, ALB, PX

The Hain Celestial Group, Inc.(NASDAQ:HAIN): Citigroup added Hain Celestial to its Top Picks Live list on expectations the company is well positioned for solid growth in FY12. The firm keeps a Buy rating on the stock with a $46 price target.

GTX Inc.(NASDAQ:GTXI): Citigroup raised its price target for GTx citing to the addition of Ostarine to its model. The firm sees a high likelihood of success for the company’s Phase 3 trials of Ostarine for the prevention and treatment of cancer-related muscle wasting, and expects the results to be announced in about a year. Citi believes Ostarine will be worth at least $11 per share should the trials be positive and keeps a Buy rating on GTx shares.

Temple-Inland Inc.(NYSE:TIN): Deutsche Bank believes comments in the press release by International Paper (NYSE:IP) and Temple-Inland (NYSE:TIN) announcing the extension of the Justice Department review strongly suggest that the deal will ultimately be consummated. However, Deutsche notes the deal has encountered greater than expected scrutiny from the Justice Department, and adds that corrugated box plants seem the most likely divestiture targets to gain approval.

Albemarle Corp.(NYSE:ALB): Citigroup added Albermarle (NYSE:ALB) to its Top Picks Live list in place of Praxair (NYSE:PX) following the company’s better than expected Q4 results. Citi keeps a Buy rating on Albermarle with a $74 price target.

Praxair Inc.(NYSE:PX): Citigroup removed Praxair from its Top Picks Live list citing currency headwinds in 2012 but keeps a Buy rating on the stock.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at